PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209,156 | +95.4% | 67,688 | +184.5% | 0.00% | – |
Q2 2023 | $107,046 | -62.1% | 23,788 | -51.9% | 0.00% | – |
Q1 2023 | $282,127 | +196.3% | 49,496 | +214.0% | 0.00% | – |
Q4 2022 | $95,215 | -33.9% | 15,764 | -27.5% | 0.00% | – |
Q3 2022 | $144,000 | -37.9% | 21,735 | -50.9% | 0.00% | – |
Q2 2022 | $232,000 | +39.8% | 44,295 | +83.9% | 0.00% | – |
Q1 2022 | $166,000 | -88.2% | 24,090 | -78.7% | 0.00% | – |
Q4 2021 | $1,411,000 | +420.7% | 113,335 | +1208.9% | 0.00% | – |
Q3 2021 | $271,000 | -49.2% | 8,659 | -53.5% | 0.00% | – |
Q2 2021 | $533,000 | -71.7% | 18,617 | -57.2% | 0.00% | – |
Q1 2021 | $1,885,000 | -24.8% | 43,509 | -47.7% | 0.00% | -100.0% |
Q3 2020 | $2,507,000 | – | 83,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |